These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6855001)

  • 21. [International normalized ratio (INR) for optimal anticoagulant therapy].
    Uetsuka Y; Katsuki T; Aosaki M; Iwade K; Hashimoto A; Koyanagi H; Saito M; Yaginuma Y; Hosoda S
    Kokyu To Junkan; 1993 Sep; 41(9):885-90. PubMed ID: 8210749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of oral anticoagulant therapy by measuring plasma prothrombin fragment 1 + 2.
    Takahashi H; Wada K; Satoh N; Takakuwa E; Furuta R; Yoshino N; Shibata A
    Blood Coagul Fibrinolysis; 1993 Jun; 4(3):435-9. PubMed ID: 8329570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Statistical comparison between prothrombin time, Owren's thrombotest and cephalin time during the surveillance of anticoagulant therapy].
    Aznar J; Fernández Pavón A; Aznar JA
    Sangre (Barc); 1972; 17(2):187-92. PubMed ID: 5035457
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).
    Cosmi B; Palareti G; Carpanedo M; Pengo V; Biasiolo A; Rampazzo P; Morstabilini G; Testa S
    Haematologica; 2000 Aug; 85(8):826-31. PubMed ID: 10942929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between Normotest and Thrombotest in patients on oral anticoagulant therapy.
    Refsum N; Arnesen H; Gilhuus-Moe CC; Godal HC
    Scand J Haematol; 1977 Apr; 18(4):333-6. PubMed ID: 854707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting the dose of warfarin for therapeutic anticoagulation.
    Sharma NK; Routledge PA; Rawlins MD; Davies DM
    Thromb Haemost; 1982 Jun; 47(3):230-1. PubMed ID: 7112495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of two methods for INR determination in a pharmacist-based oral anticoagulation clinic.
    Yamreudeewong W; Johnson JV; Cassidy TG; Berg JT
    Pharmacotherapy; 1996; 16(6):1159-65. PubMed ID: 8947990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
    Fonseca RJ; Mourão PA
    Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of prothrombin time in patients on oral anticoagulant therapy: effect of two different evacuated tubes.
    D'Angelo G; Villa C
    Haematologica; 1999 Jul; 84(7):656-7. PubMed ID: 10406912
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral anticoagulant prophylaxis and epidural catheter removal.
    Wu CL; Perkins FM
    Reg Anesth; 1996; 21(6):517-24. PubMed ID: 8956387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coagulation assays.
    Bates SM; Weitz JI
    Circulation; 2005 Jul; 112(4):e53-60. PubMed ID: 16043649
    [No Abstract]   [Full Text] [Related]  

  • 32. International Normalized Ratio (INR): an improved way to monitor oral anticoagulant therapy.
    Oertel LB
    Nurse Pract; 1995 Sep; 20(9):15-6, 21-2. PubMed ID: 7501312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. I have an artificial heart valve and am on warfarin for life. I would like to be able to test my own clotting at home. I have heard that there are test devices for this, as there are for diabetics. Why don't more warfarin patients know about them?
    Health News; 2006 Apr; 12(4):16. PubMed ID: 16583499
    [No Abstract]   [Full Text] [Related]  

  • 34. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
    Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory monitoring of oral anticoagulant therapy.
    Poller L; Samama M
    Clin Lab Med; 1994 Dec; 14(4):813-23. PubMed ID: 7874873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Warfarin does not interfere with lupus anticoagulant detection by dilute Russell's viper venom time.
    Olteanu H; Downes KA; Patel J; Praprotnik D; Sarode R
    Clin Lab; 2009; 55(3-4):138-42. PubMed ID: 19462936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship between prothrombin time international normalized ratio and thrombo test (%)].
    Numata Y; Ogata Y; Arao K; Mizumasa Y; Wakita T; Haruguchi H; Araki H; Tsuji T; Mawatari K; Shimada K
    J Cardiol; 2001 Dec; 38(6):327-35. PubMed ID: 11806090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience with Owren's thrombotest in control of anticoagulant therapy.
    Procházka J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1969; 12(5):529-36. PubMed ID: 5267590
    [No Abstract]   [Full Text] [Related]  

  • 39. Evolving concepts in the pathogenesis and treatment of arterial thrombosis.
    Chesebro JH; Toschi V; Lettino M; Gallo R; Badimon JJ; Fallon JT; Fuster V
    Mt Sinai J Med; 1995 Sep; 62(4):275-86. PubMed ID: 7565850
    [No Abstract]   [Full Text] [Related]  

  • 40. [Some aspects of newly developed instruments for blood coagulation tests].
    Matsuo T; Kario K
    Rinsho Byori; 1995 Dec; 43(12):1209-13. PubMed ID: 8569030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.